Cohort Study of Clinical and Neuroimaging Characteristics for BPPV Patients in China
Launched by FIRST AFFILIATED HOSPITAL XI'AN JIAOTONG UNIVERSITY · Jan 18, 2024
Trial Information
Current as of May 14, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a condition called benign paroxysmal positional vertigo (BPPV), which causes episodes of dizziness when a person changes their head position. The goal is to understand how BPPV affects patients' physical health, mental well-being, and blood tests. Researchers also want to create a database that uses advanced brain imaging techniques to identify patients who might still experience dizziness after treatment. This work aims to improve how BPPV is diagnosed and managed in China.
To participate in this study, individuals must have a confirmed diagnosis of BPPV, or they can be healthy volunteers who have never had BPPV. However, people with certain serious medical conditions, such as brain tumors or mental health disorders, cannot join. Those who take part can expect to undergo assessments that will help researchers learn more about BPPV and how to treat it effectively. Overall, this study is important for finding better ways to help people who struggle with dizziness related to BPPV.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Confirmed diagnosis of BPPV/Healthy subjects who have not had BPPV
- Exclusion Criteria:
- • History of organic diseases in central nervous system and mental disorder, such as tumors, infections, depressive disorder, schizophrenia, etc. Claustrophobic
About First Affiliated Hospital Xi'an Jiaotong University
The First Affiliated Hospital of Xi'an Jiaotong University is a leading medical institution renowned for its commitment to advancing healthcare through clinical research and innovative treatment approaches. As a prominent academic hospital in China, it integrates clinical practice, education, and research, fostering a collaborative environment that enables the development of cutting-edge therapies and medical technologies. With a multidisciplinary team of experts and state-of-the-art facilities, the hospital plays a pivotal role in conducting high-quality clinical trials that aim to improve patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Xi'an, Shaanxi, China
Xi'an, Harbin, China
Patients applied
Trial Officials
Yuan Wang, M.D.
Principal Investigator
First Affiliated Hospital of Xian Jiaotong University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported